Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 4Mycoses 3Hematologic Neoplasms 3Myelodysplastic Syndromes 2Leukemia 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Neoplasms 1Mucormycosis 1Invasive Fungal Infections 1Glioma 1Glioblastoma 1Genetic Predisposition to Disease 1Candidiasis 1Breast Neoplasms 1Bone Marrow Neoplasms 1Bone Marrow Failure Disorders 1Aspergillosis 1Anemia, Aplastic 1

Interventions

Voriconazole 3Itraconazole 2Amphotericin B 2posaconazole 1liposomal amphotericin B 1Therapeutics 1Solutions 1Caspofungin 1Blood Specimen Collection 1Anidulafungin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Invasive Fungal Infections × posaconazole × Clear all
NCT00750737 2016-09-29

Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC)

M.D. Anderson Cancer Center

Phase 3 Completed
46 enrolled 6 charts
Other hematologic neoplasm

Invasive Fungal Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡